Royalty Pharma plc Class A Share Price
NASDAQ: RPRX | Large CapRoyalty Pharma plc Class A Stock Performance
Royalty Pharma plc Class A Share Price Today
As of 3 November 2026, Royalty Pharma plc Class A's share price is $66.53. The stock opened at $66.95, compared to its previous close of $67.19. During today's trading session, Royalty Pharma plc Class A's share price traded between $66.42 and $67.03, with an average price of $66.73. Over the past 52 weeks, the stock has recorded a high of $67.70 and a low of $36.27. In terms of performance, Royalty Pharma plc Class A's share price has risen by 19.31% over the last six months and is up 66.13% on a year-on-year basis.
Royalty Pharma plc Class A Share Price Chart
Royalty Pharma plc Class A Quarterly Profit & Loss
All figures in USD
Royalty Pharma plc Class A Annual Profit & Loss
All figures in USD
About Royalty Pharma plc Class A
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Royalty Pharma plc Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $66.95 | $66.56 | -0.89% |
Oct 2026 | $58.26 | $67.17 | +15.02% |
Sep 2026 | $61.83 | $58.40 | -5.69% |
Aug 2026 | $57.97 | $61.92 | +5.98% |
Jul 2026 | $56.09 | $58.42 | +4.18% |
Jun 2026 | $55.16 | $56.08 | +0.57% |
May 2026 | $49.95 | $55.76 | +11.31% |
Apr 2026 | $48.19 | $50.09 | +4.43% |
Mar 2026 | $45.98 | $47.97 | +3.81% |
Feb 2026 | $41.53 | $46.21 | +10.91% |
Jan 2026 | $38.67 | $41.66 | +7.83% |
Dec 2025 | $40.15 | $38.64 | -3.51% |